Predictive Prescriptions
June 19, 2025
Alex Tropsha is part of a multi-million dollar, federally funded project using machine learning to identify new uses for existing drugs.
UNC Eshelman School of Pharmacy
Rewriting the Prescription
May 27, 2025
Joshua Niznik is blending data and empathy to shift the culture of prescribing medications in older adults — starting with when to stop.
Boldly Breaking Barriers
January 27, 2025
Sam Lai has founded multiple startups by studying underexplored processes in the body — like mucus production.
Let’s Get Clinical
May 20, 2024
Researchers across Carolina manage clinical trials to get novel treatments and interventions into the hands of those who need them most.
READDI, Not Reactive
January 19, 2021
For decades, scientists warned of the potential for a global coronavirus outbreak. But when SARS-CoV-2 emerged, no therapeutics, drugs, or vaccines were readily available. The Rapidly Emerging Antiviral Drug Development Initiative (READDI) — founded by researchers at UNC and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.
Aaron Anselmo
May 20, 2020
Aaron Anselmo is an assistant professor in the UNC Eshelman School of Pharmacy. He develops new strategies and technologies that alter the microbiome by removing pathogens and increasing beneficial bacteria.
Tojan Rahhal
April 27, 2016
Tojan Rahhal is a fourth-year PhD student studying pharmaceutical sciences in the UNC Eshelman School of Pharmacy. Under the guidance of Joseph DeSimone, her research focuses on the delivery of therapeutics to the lungs. She is also the chair of UNC’s Women in Science group.